Publicacions en col·laboració amb investigadors/es de Queen Mary University of London (20)

2024

  1. Addressing Ancestry and Sex Bias in Pharmacogenomics

    Annual review of pharmacology and toxicology, Vol. 64, pp. 53-64

  2. Mapping the Pharmacogenetic Landscape in a Ugandan Population: Implications for Personalized Medicine in an Underrepresented Population

    Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 4, pp. 980-995

  3. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Subjective quality of life factorial structure across mental disorders: should we switch to assessing dimensions?

    European Archives of Psychiatry and Clinical Neuroscience, Vol. 273, Núm. 4, pp. 953-961

  3. Which psychological interventions improve quality of life in patients with schizophrenia-spectrum disorders? A meta-analysis of randomized controlled trials

    Psychological Medicine

2020

  1. Associations of Personality Traits and Emotional Intelligence: Comparing Individuals in Rehabilitation from Drug Misuse, Occasional Users and Non-Users

    Substance Use and Misuse, Vol. 55, Núm. 2, pp. 252-260

  2. Factorial structure of the Manchester Short Assessment of Quality of Life in patients with schizophrenia-spectrum disorders

    Quality of Life Research, Vol. 29, Núm. 3, pp. 833-841

  3. PARP-1 activation after oxidative insult promotes energy stress-dependent phosphorylation of YAP1 and reduces cell viability

    The Biochemical journal, Vol. 477, Núm. 23, pp. 4491-4513

2019

  1. Do male university students sleep well when they feel well? Exploring the role of depression and anxiety as mediators

    Psychology, Health and Medicine, Vol. 24, Núm. 8, pp. 951-961

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

2014

  1. A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

    Infection, Vol. 42, Núm. 4, pp. 757-762

  2. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2013

  1. Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients

    PLoS ONE, Vol. 8, Núm. 5

2012

  1. Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: The EuroSIDA study

    PLoS ONE, Vol. 7, Núm. 7

2011

  1. A376s in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy

    Journal of Infectious Diseases, Vol. 204, Núm. 5, pp. 741-752

  2. Acute psychopathology as a predictor of global functioning in patients with ICD-10 non-affective psychosis: A prospective study in 11 European countries

    Schizophrenia Research, Vol. 131, Núm. 1-3, pp. 105-111

2010

  1. Dialysis and renal transplantation in HIV-infected patients: A European survey

    Journal of Acquired Immune Deficiency Syndromes, Vol. 55, Núm. 5, pp. 582-589

2009

  1. Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal

    Clinical Infectious Diseases, Vol. 48, Núm. 8, pp. 1138-1151

2008

  1. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

    AIDS, Vol. 22, Núm. 3, pp. 367-376